NAPOLITANO, FABIANA
 Distribuzione geografica
Continente #
EU - Europa 213
NA - Nord America 203
AS - Asia 30
AF - Africa 12
SA - Sud America 1
Totale 459
Nazione #
US - Stati Uniti d'America 201
IT - Italia 164
NL - Olanda 29
CI - Costa d'Avorio 12
IN - India 11
DE - Germania 9
CN - Cina 8
PK - Pakistan 7
FR - Francia 5
CA - Canada 2
MY - Malesia 2
SE - Svezia 2
AR - Argentina 1
BE - Belgio 1
BG - Bulgaria 1
GB - Regno Unito 1
JP - Giappone 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 459
Città #
Naples 63
Chandler 41
Amsterdam 28
Ashburn 19
Napoli 15
Millbury 10
Lawrence 9
Pune 9
Casoria 6
Seattle 6
Beijing 5
Des Moines 5
Fucecchio 4
Turin 4
Boston 3
Casagiove 3
Islamabad 3
Redwood City 3
Salerno 3
Fairfield 2
Krefeld 2
Kuala Lumpur 2
Lahore 2
Lomazzo 2
Luco dei Marsi 2
Marcianise 2
Milan 2
Ottawa 2
Prato 2
Rawalpindi 2
San Mateo 2
Wilmington 2
Augusta 1
Buenos Aires 1
Cava De' Tirreni 1
Dearborn 1
Falkenstein 1
Frankfurt am Main 1
Genoa 1
Hanover 1
Kagoya 1
Kronberg 1
La Louvière 1
Lanuvio 1
Leawood 1
Marigliano 1
Mirabella Eclano 1
Montalbano Jonico 1
Mumbai 1
Nanchang 1
Nijmegen 1
Pizzo 1
Pomigliano d'Arco 1
Pozzuoli 1
Rho 1
Sacramento 1
San Jose 1
San Sebastiano al Vesuvio 1
Sant'Elia Fiumerapido 1
Sesto Fiorentino 1
Shenyang 1
Sofia 1
Sparanise 1
Stockholm 1
Tashkent 1
Torino 1
Washington 1
Witney 1
Zhengzhou 1
Totale 302
Nome #
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 84
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 52
Mechanisms of resistance to mTOR inhibitors 42
A comparative study of the effects of platinum (Ii) complexes on β-amyloid aggregation: Potential neurodrug applications 42
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review. 41
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules 40
Use of folfirinox or nab-paclitaxel plus gemcitabine for the treatment of locally advanced pancreatic adenocarcinoma: A single institution observational study 38
A review of the use of next generation sequencing methodologies to identify biomarkers of resistance to CDK4/6 inhibitors in ER+/HER2- breast cancer 35
Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: a systematic review 27
Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer 25
RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challenges 24
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer 16
Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLC 15
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer 14
Totale 495
Categoria #
all - tutte 2.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 2 3
2019/202039 5 0 2 3 5 7 3 2 1 2 8 1
2020/202146 3 0 0 2 7 3 12 0 12 4 3 0
2021/202283 0 0 9 7 1 3 4 5 4 6 23 21
2022/2023182 10 12 4 6 21 15 11 21 39 21 13 9
2023/2024136 4 17 38 12 5 28 3 22 3 4 0 0
Totale 495